Serina Therapeutics, Inc. Deferred Tax Assets, Operating Loss Carryforwards, Domestic
Serina Therapeutics, Inc. (SER) had Deferred Tax Assets, Operating Loss Carryforwards, Domestic of $59.70 million as of 2023-12-31, per its 10-K filed 2024-03-22.
Discontinued › Notes › Income Taxes › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic · last filed 2024-03-22
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $59.70M.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $52.80M.
- 2021-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $48.60M.
- 2020-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $49.20M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards, Domestic |
|---|---|
| 2023-12-31 | $59.70M 10-K · filed 2024-03-22 |
| 2022-12-31 | $52.80M 10-K · filed 2023-03-31 |
| 2021-12-31 | $48.60M 10-K · filed 2022-03-29 |
| 2020-12-31 | $49.20M 10-K · filed 2021-03-31 |
| 2019-12-31 | $42.00M 10-K/A · filed 2020-03-31 |
| 2018-12-31 | $31.50M 10-K · filed 2019-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| TALPHERA, INC. (TLPH) | United States | $0.060B |